These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
| | | | | | 1 | | | |
| | | | | | 2 | | | |
| | | | | | 8 | | | |
| | | | | | 12 | | | |
| | | | | | 19 | | | |
| | | | | | 20 | | | |
| | | | | | 23 | | | |
| | | | | | 24 | | | |
| | | | | | 26 | | | |
| | | | | | 28 | | |
|
Name
|
| |
Class
|
| |
Age
|
| |
Position
|
| |
Director
Since |
| |
Current
Term Expiring |
| |
Expiration
of Term for which Nominated |
|
| Directors/Nominees | | | | | | | | | | | | | | | | | | | |
|
Charles Nearburg
(1)(2)
|
| |
I
|
| |
75
|
| | Director | | |
2025
|
| |
2025
|
| |
2028
|
|
|
Stuart Kovensky
(1)(2)
|
| |
II
|
| |
58
|
| | Director | | |
2024
|
| |
2026
|
| |
—
|
|
|
Meltem Demirors
(1)(2)
|
| |
II
|
| |
38
|
| | Director | | |
2024
|
| |
2026
|
| |
—
|
|
|
Jonathan Marshall
|
| |
III
|
| |
62
|
| | Director | | |
2024
|
| |
2027
|
| |
—
|
|
|
Robert I. Kauffman
|
| |
III
|
| |
62
|
| |
Chairman and Chief Executive Officer
|
| |
2024
|
| |
2027
|
| |
—
|
|
| | | |
For the Fiscal
Year ended December 31, 2024 |
| |||
|
Audit fees
(1)
|
| | | $ | 29,000 | | |
|
Audit-related fees
(2)
|
| | | $ | 11,000 | | |
|
Tax fees
(3)
|
| | | $ | — | | |
|
All other fees
|
| | | $ | — | | |
|
Total fees
|
| | | $ | 40,000 | | |
| | | |
Class A ordinary shares
|
| |
Class B ordinary shares
|
| | | | | | | ||||||||||||||||||
|
Name and Address of Beneficial Owner
(1)
|
| |
Number of
shares benefically owned |
| |
Approximate
percentage of class |
| |
Number of
shares benefically owned |
| |
Approximate
percentage of class |
| |
Approximate
percentage of ordinary class |
| |||||||||||||||
|
Aldel Investors II LLC
(2)(3)
|
| | | | 440,000 | | | | | | * | | | | | | 5,470,714 | | | | | | 88.8 % | | | | | | 18.3 % | | |
|
Robert I. Kauffman
(3)(4)
|
| | | | 440,000 | | | | | | * | | | | | | 5,558,214 | | | | | | 90.2 % | | | | | | 18.6 % | | |
|
Hassan R. Baqar
|
| | | | — | | | | | | — | | | | | | 70,000 | | | | | | 1.14 % | | | | | | * | | |
|
Charles Nearburg
|
| | | | — | | | | | | — | | | | | | 25,000 | | | | | | * | | | | | | * | | |
|
Stuart Kovensky
|
| | | | — | | | | | | — | | | | | | 25,000 | | | | | | * | | | | | | * | | |
|
Jonathan Marshall
|
| | | | — | | | | | | — | | | | | | 25,000 | | | | | | * | | | | | | * | | |
|
Meltem Demirors
|
| | | | — | | | | | | — | | | | | | 25,000 | | | | | | * | | | | | | * | | |
|
All officers, directors and director nominees as a group (6 persons)
|
| | | | 440,000 | | | | | | * | | | | | | 5,728,214 | | | | | | 93.2 % | | | | | | 19.2 % | | |
| | Proposal 1 — Director Proposal | | |
FOR
|
| |
AGAINST
|
| |
ABSTAIN
|
|
| | Elect one Class I Director, Charles Nearburg, to the Board to serve as a director of the Company, which we refer to as the “Director Proposal.” | | |
☐
|
| |
☐
|
| |
☐
|
|
| | Proposal 2 — Auditor Proposal | | |
FOR
|
| |
AGAINST
|
| |
ABSTAIN
|
|
| | Ratify the selection by our Audit Committee of Fruci & Associates II, PLLC to serve as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025. The Audit Committee is directly responsible for appointing the Company’s independent registered public accounting firm. | | |
☐
|
| |
☐
|
| |
☐
|
|
| | Proposal 3 — Adjournment Proposal | | |
FOR
|
| |
AGAINST
|
| |
ABSTAIN
|
|
| | Approve the adjournment of the Annual General Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of the Director Proposal and/or the Auditor Proposal, which we refer to as the “Adjournment Proposal.” | | |
☐
|
| |
☐
|
| |
☐
|
|
| |
Dated: , 2025
Shareholder’s Signature
|
|
| |
Shareholder’s Signature
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|